Sandu Pharmaceuticals reports standalone net loss of Rs 0.05 crore in the March 2015 quarter

Sales rise 15.25% to Rs 11.41 crore

Net loss of Sandu Pharmaceuticals reported to Rs 0.05 crore in the quarter ended March 2015 as against net profit of Rs 0.17 crore during the previous quarter ended March 2014. Sales rose 15.25% to Rs 11.41 crore in the quarter ended March 2015 as against Rs 9.90 crore during the previous quarter ended March 2014. ParticularsQuarter EndedMar. 2015Mar. 2014% Var.Sales11.419.90 15 OPM %3.686.46 -PBDT0.140.53 -74 PBT0.030.38 -92 NP-0.050.17 PL

Powered by Capital Market - Live News